News

Is Walgreens Boots Alliance Stock a Smart Investment Now?

Is Walgreens Boots Alliance Stock a Smart Investment Now?

Understanding Walgreens Boots Alliance and Its Current Market Position

If you're on the lookout for high-yield dividend opportunities in the stock market, Walgreens Boots Alliance (NASDAQ: WBA) might catch your interest. This company is a prominent player, especially when it comes to discussions about dividend stocks.

This year, Walgreens made a significant adjustment by lowering its quarterly dividend payout to $0.25. Despite this reduction, the stock price has remained under $10 per share, which could offer an attractive dividend yield for new investors who decide to buy in at these levels.

While investing in stocks that are currently out of favor can lead to substantial returns, it’s important to tread carefully. Investing in stocks that have seen sharp declines can also result in considerable losses, as we will see with Walgreens Boots Alliance.

Current Challenges Facing Walgreens Stock

Understanding the challenges that Walgreens is facing is essential. From late 2023 to the end of August, Walgreens shares plummeted by around 64.6%. The company is grappling with intense competition from online retailers and pharmacy benefits managers (PBMs), which is significantly impacting its performance.

In its fiscal third quarter, Walgreens reported a modest sales growth of 2.3% in its U.S. pharmacy segment. However, this growth has come at a steep price; the adjusted operating income fell by 47.9%, highlighting a sharp decline in profitability related to prescription fulfillment.

Interestingly, three major PBMs control about 80% of all prescriptions filled in the U.S. They also own mail-order and specialty pharmacies, giving them a competitive edge over Walgreens. Notably, CVS Health, a key competitor, operates its retail chain and directly competes with Walgreens, which lacks an affiliated PBM.

Assessment of Walgreens’ Strategic Moves

In addition to the challenges within its pharmacy business, Walgreens has been trying to reposition itself as a significant healthcare service provider through its partnership with VillageMD and Cigna. Unfortunately, this endeavor has not unfolded as expected.

In an effort to expand, VillageMD acquired Summit Health-CityMD for $8.9 billion, which led to an enormous impairment charge of $12.4 billion—over $5 billion of which Walgreens had to absorb. So far in fiscal 2024, this segment has reported an adjusted operating loss of $151 million.

Despite these setbacks, a recent analysis indicated that 75% of Walgreens' U.S. locations play a crucial role in generating profits for the healthcare segment, suggesting there is potential for improved returns through operational changes.

Paving a Way Forward for Walgreens

Even with the complexities of navigating PBMs and the hurdles of its current business model, there is a glimmer of hope for Walgreens. There are intriguing developments on the horizon regarding potential changes in the PBM industry that could create a more level playing field.

The Federal Trade Commission (FTC) recently released a report expressing significant concerns about PBM practices, signaling possible legal actions. If the FTC successfully implements changes, it could positively alter the competitive landscape for Walgreens.

The company is actively working towards profitability in its U.S. healthcare segment, having managed to reduce its adjusted operating loss to $22 million in the fiscal third quarter, a notable improvement compared to the larger losses seen in previous periods.

Evaluating the Investment Opportunity in Walgreens

With Walgreens' stock trading at a fraction of its potential earnings, some investors may view this as a prime opportunity. Currently, the stock is priced at just 3.2 times the average of its lowered earnings outlook, indicating a significant discount that might attract value-focused investors.

However, potential investors should proceed with caution. During a recent conference call, CEO Tim Wentworth acknowledged that the existing pharmacy model is unsustainable. While prompt governmental reforms could be advantageous, it remains unclear when—or if—these changes will take place. For those seeking consistent income, it may be wise to take a step back and monitor the company's progress in the market.

Should You Bet on Walgreens Boots Alliance Right Now?

Before making any investment decisions, it's crucial to carefully consider the associated risks. Given its recent performance and strategic shifts, Walgreens Boots Alliance certainly presents an interesting case for investment.

Frequently Asked Questions

What are the current challenges facing Walgreens Boots Alliance?

Walgreens is facing significant competition from online retailers and pharmacy benefits managers, which is impacting its sales and overall profitability.

How has Walgreens adjusted its dividend policy?

This year, Walgreens cut its quarterly dividend payout to $0.25 in response to ongoing financial challenges.

What is Walgreens’ strategy for future growth?

The company is focusing on enhancing profitability within its healthcare segment and is exploring potential regulatory changes in the PBM industry.

Is Walgreens a good investment option now?

While its stock is currently undervalued, investing carries inherent risks, so a cautious approach is advisable.

Who is Walgreens' primary competitor?

CVS Health stands as the leading competitor in the retail pharmacy market, operating both a substantial retail chain and pharmacy benefits managers.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Navan’s Travel Survey Sells Friction as a Business Case

Updated Category News Views 154

A forgotten charger can turn a routine trip into a small mutiny. That is the useful little truth sitting underneath Navan’s new survey of 2,000 Americans who travel for leisure or business. The company is poking at the annoyances people carry from the bedroom packing pile to the jet bridge: forgotten items, rushed airport arrivals, pre-flight drinks, chatty strangers,...

Continue Reading
SecureSpace Plants a Fifth Flag in Miami Beach Storage

Updated Category News Views 111

A small box on Alton Road may carry outsized weight Miami Beach does not hand out cheap, easy real estate wins, which is why SecureSpace's opening at 633 Alton Road deserves a closer look than its modest footprint might suggest. The newly rebranded SecureSpace Miami Beach facility has 18,358 square feet of traditional storage and locker space spread across 536 units, plus...

Continue Reading
Docusign Pushes Contract Data Into ChatGPT Sales Tools

Updated Category News Views 187

Contracts are where sales momentum goes to get lost, buried under old PDFs, approval chains, and somebody’s half-finished CRM note. Docusign’s November 17, 2026 launch is a sensible attempt to drag that information into the place sellers may increasingly spend their working day: ChatGPT for Sales. The company’s new plugin lets a sales rep pull agreement intelligence...

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 196

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
ELEGOO's Formnext Push Tests a Broader 3D Ambition

Updated Category News Views 123

Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...

Continue Reading
AMPERA Joins Berto to Power Future Energy Innovations

Updated Category News Views 172

The Power Play You Didn't See Coming AMPERA and Berto just made a move that could stir up some serious waves in the energy sector. They've inked a business combination deal set to push advanced energy technology to the forefront. With AMPERA's valuation clocking in at roughly $900 million, this partnership aims to bring cutting-edge power solutions from concept to market....

Continue Reading
Kobo and CloudLibrary Make Library Ebooks Much Easier

Updated Category News Views 107

A tiny button can change whether a digital service gets used Borrowing an ebook ought not feel like assembling a radio in a dark garage, yet that is roughly where library reading has landed for plenty of people. OCLC's new CloudLibrary integration with Kobo strips out a particularly annoying step: U.S. and Canadian users can link accounts once, borrow a title, and have it...

Continue Reading
MAXHUB's Canon Office Test Puts Hybrid Work on Trial

Updated Category News Views 68

Thirty-nine devices scattered through a new Hong Kong office may not sound earth-shaking, but this is how workplace technology actually earns its keep: not under trade-show lights, but when somebody is late to a meeting in another time zone and the room has to work anyway. MAXHUB and Canon Hong Kong have launched the first officially delivered Co-Create 100 project...

Continue Reading
STORMER LAT Targets Sewer Crews' Costly Access Delays

Updated Category News Views 65

A buried cleanout can turn a simple sewer inspection into a scheduling circus. That unglamorous headache is exactly where FIBERSCOPE is aiming its new STORMER LAT Lateral Launch Camera System, announced November 17, 2026. This is not some flashy consumer gadget hunting for attention; it is field equipment built around a painfully ordinary municipal problem: crews often...

Continue Reading
VisionX AI Bets on Graphs to Track Crypto Crime Nets

Updated Category News Views 74

Money laundering rarely travels in a straight line, and that is precisely the sore spot VisionX AI is trying to jab. The Singapore-based RegTech company has introduced AEGIS, a proprietary Large Graph Model built around financial-crime networks, alongside TraceX, a blockchain investigation platform meant to turn that network view into usable leads. It is a sensible...

Continue Reading

Top 5 Most Recently Viewed Articles

Rocket Lab USA's Earnings Predictions and Market Insights

Updated Category News Views 157

Earned Expectations from Rocket Lab USA Rocket Lab USA (NASDAQ: RKLB) is gearing up for its quarterly earnings report, anticipated by investors with curiosity and optimism. The forthcoming announcement promises to deliver crucial insights into the company's financial health and growth trajectory. Expected Earnings Snapshot Analysts forecast that Rocket Lab will register...

Continue Reading
Upcoming Q2 Financial Results Announcement from Parkland

Updated Category News Views 108

Exciting News from Parkland Corporation Parkland Corporation, known for its dedication to providing quality fuel and convenience products, is gearing up for its next financial milestone. The company anticipates unveiling its second quarter results for 2025, a pivotal moment for investors and stakeholders alike. Key Announcement Details Scheduled to be disclosed after the...

Continue Reading
FLSmidth Secures Major Flotation Technology Contract for Iron Ore

Updated Category News Views 201

FLSmidth Secures Major Flotation Technology Contract for Iron Ore A leading Indian miner and steel producer has made a significant decision by selecting FLSmidth & Co. A/S to deliver a comprehensive flotation technology package for their state-of-the-art iron ore beneficiation plant. This facility is poised to be among the largest and most efficient of its kind globally,...

Continue Reading
Arthur J. Gallagher & Co. Plans Financial Results Conference

Updated Category News Views 118

Arthur J. Gallagher & Co. Announces Key Earnings Details Arthur J. Gallagher & Co. (NYSE: AJG) is gearing up to share its financial results for the fourth quarter of 2025. The announcement will be made after market closure on Thursday, January 29, 2026. Following this release, interested investors will find a printer-friendly version on the company’s official website,...

Continue Reading
Exelixis Faces Investor Scrutiny Amid Financial Reporting Concerns

Updated Category News Views 234

Exelixis under Investigation by Pomerantz Law Firm Pomerantz LLP, a renowned law firm, has initiated an investigation concerning investors of Exelixis, Inc. (NASDAQ: EXEL). This inquiry focuses on potential securities fraud or other unlawful practices involving the company and its leadership. Insights into Recent Financial Performance Recently, Exelixis reported its...

Continue Reading